To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis biotech company has ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

During a recent appearance on the “So True with Caleb Hearon” podcast, co-director Lilly Wachowski was asked about certain right-wing groups attaching their ideologies to her 1999 sci-fi masterpiece ...

Ready to unlock your full math potential? 🎓Follow for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at a ...

TEAD proteins are the transcriptional effectors of the Hippo pathway and are a promising target for cancer therapy, with several TEAD inhibitors advancing in the clinic. Drug-like TEAD inhibitors are ...

Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor's breakthrough RNA-based diagnostic approach at the RNA Society's 30th Annual Meeting. The talk, presented by Dr.

SAN DIEGO--(BUSINESS WIRE)--Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor’s breakthrough RNA-based diagnostic approach at the RNA Society’s 30th Annual Meeting.